Overview
Matthijs Dolman practices in Utrecht, Netherlands. Mr. Dolman is rated as an Advanced expert by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Rhabdomyosarcoma.
His clinical research consists of co-authoring 40 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles in the study of Neuroblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- NeuroblastomaMr. Dolman isAdvanced. Learn about Neuroblastoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Mr. Dolman isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Mr. Dolman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMr. Dolman isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Childhood Acute Myeloid LeukemiaMr. Dolman isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Gliomatosis CerebriMr. Dolman isExperienced. Learn about Gliomatosis Cerebri.
- LeukemiaMr. Dolman isExperienced. Learn about Leukemia.